908 Devices completed the acquisition of TRACE Analytics.

908 Devices, a provider of desktop mass spec devices for chemical and biomolecular analysis, completed the acquisition of TRACE Analytics, a provider of on-line analysis and sampling systems for biotech applications. Financial terms were not disclosed. “The addition of TRACE Analytics enables us to take a measurable step forward in our goal to build a connected and comprehensive bioanalytics platform. We are excited to have the TRACE Analytics team join us as we work together to meet the needs of our customers with on-line devices that provide actionable insights and enable Bioprocessing 4.0," Dr. Kevin J. Knopp, 908 Devices CEO and Co-founder.